Bristol-Myers Squibb Company vs Medline Industries, LP: FDA Enforcement Comparison

Medline Industries, LP has been the subject of 266 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Bristol-Myers Squibb Company.

Bristol-Myers Squibb Company: 0 warning letters, 1 recall, 0 approval records, 0 Form 483s.

Medline Industries, LP: 0 warning letters, 266 recalls, 0 approval records, 0 Form 483s.

Side by side

Bristol-Myers Squibb Company — Warning letters0

Medline Industries, LP — Warning letters0

Bristol-Myers Squibb Company — Recalls1

Medline Industries, LP — Recalls266

Bristol-Myers Squibb Company — Approval records0

Medline Industries, LP — Approval records0

Bristol-Myers Squibb Company — Form 483s0

Medline Industries, LP — Form 483s0

Timeline

Bristol-Myers Squibb Company

Most recent FDA action: October 29, 2025

Full history →

Medline Industries, LP

Most recent FDA action: July 8, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Bristol-Myers Squibb Company vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed July 17, 2026. https://argushq.ai/compare/bristol-myers-squibb-company-vs-medline-industries-lp

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗